Cargando…
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study
The availability of disease modifying therapies for spinal muscular atrophy (SMA) have created an urgent need to identify clinically meaningful biomarkers that provide insight into disease progression and therapeutic response. microRNAs (miRNA) have been shown to be involved in the pathogenesis of S...
Autores principales: | D’Silva, Arlene M., Kariyawasam, Didu, Venkat, Pooja, Mayoh, Chelsea, Farrar, Michelle A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865256/ https://www.ncbi.nlm.nih.gov/pubmed/36678797 http://dx.doi.org/10.3390/pharmaceutics15010170 |
Ejemplares similares
-
Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy
por: Kariyawasam, Didu S. T., et al.
Publicado: (2019) -
Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme
por: D'Silva, Arlene M, et al.
Publicado: (2021) -
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen
por: Kariyawasam, Didu, et al.
Publicado: (2021) -
“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy
por: Kariyawasam, Didu S.T., et al.
Publicado: (2021) -
Incidence of Duchenne muscular dystrophy in the modern era; an Australian study
por: Kariyawasam, Didu, et al.
Publicado: (2022)